Company: GRT US Holding / Averitas Pharma, Inc.
Job title: Head Medical Affairs
Efficacy & Tolerability of a Topical High Concentration Capsaicin (TRPV1 Agonist) in PHN & PDPN of the Feet 9:00 am
In clinical trials most common ARs were application site reactions Sharing statistically significant improvements in pain relief in patients with PDPN and PHN Feedback on clinical trial results: It was well tolerated and was not associated with any negative functional or neurological safety consequencesRead more
day: Day Two